Funding for clin 0001

Ended Definitive Contract Awarded Last action

Contract number
W81XWH15C0117
Awardee
Awarding agency
Obligated
$5,864,593

Award facts

Opportunity
Contract value 78% obligated
$7,484,649.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Westlake, MD 20817, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00016 $76,709
Other Administrative Action P00015 $0
Change Order P00014 -$124,624
Supplemental Agreement for work within scope P00013 · Changes - revised SOW and POP $0
Change Order P00012 $0
Change Order P00011 -$1,572,141
Change Order P00010 $0
Change Order P00009 · R & d service contract - advanced development of gamma-tocotrienol as a radiation countermeasure. $0
Change Order P00008 · Revised SOW $0
Change Order P00007 · Changes modification $0
Other Administrative Action P00006 · Change COR 0001 $0
Other Administrative Action P00005 $1,687,897
Other Administrative Action P00004 -$1,687,897
Change Order P00003 -$292,817
Change Order P00002 $0
Other Administrative Action P00001 $0
Original award $7,777,466
Show all 17

About this award

This federal contract award, W81XWH15C0117, was issued by the Medical Command (MEDCOM) of the Department of Defense to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF), a nonprofit organization, to provide funding for Clinical Line Item 0001. The $7,484,649 cost-plus-fixed-fee contract supports HJF's work as a prime contractor and grantee for the DoD, VA, and other federal agencies, delivering specialized services for military medical research, combat casualty care, traumatic brain injury studies, and more.

The contract has no set-aside designation, reflecting HJF's unique position and capabilities in supporting military medicine. Key subcontractors include the University of Arkansas for Medical Sciences, which is conducting research on the use of gamma-tocotrienol as a radiation countermeasure, and Bioqual, Inc., which is providing housing and care for the nonhuman primate study. This contract award is associated with HJF's broader portfolio of federal contract vehicles and grant awards focused on advancing military and veteran healthcare initiatives.

Quick answers

Who was awarded contract W81XWH15C0117?

W81XWH15C0117 was awarded to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. by Medical Command (Department of the Army) on September 16, 2015.

How much is contract W81XWH15C0117 worth?

The government has obligated $5,864,593 on W81XWH15C0117. Its current value, with exercised options, is $7,484,649.

Was contract W81XWH15C0117 competed?

The extent of competition for W81XWH15C0117 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award